Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Dbv Technologies ADR (DBVT)

Dbv Technologies ADR (DBVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 65,615
  • Shares Outstanding, K 20,569
  • Annual Sales, $ 15,730 K
  • Annual Income, $ -72,730 K
  • EBIT $ -105 M
  • EBITDA $ -119 M
  • 60-Month Beta 0.64
  • Price/Sales 4.17
  • Price/Cash Flow N/A
  • Price/Book 1.14

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -2.00
  • Number of Estimates 1
  • High Estimate -2.00
  • Low Estimate -2.00
  • Prior Year -0.60
  • Growth Rate Est. (year over year) -233.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.40 +35.42%
on 11/25/24
4.50 -27.78%
on 12/03/24
+0.90 (+38.59%)
since 11/22/24
3-Month
2.20 +47.43%
on 11/19/24
5.45 -40.37%
on 10/23/24
-0.25 (-7.16%)
since 09/23/24
52-Week
2.20 +47.43%
on 11/19/24
10.70 -69.63%
on 12/27/23
-5.96 (-64.72%)
since 12/22/23

Most Recent Stories

More News
Why Shares of DBV Technologies Jumped Thursday

The New England Journal of Medicine reported phase 3 trial details regarding the company's peanut allergy treatment for toddlers.

DBVT : 3.21 (+0.63%)
Why DBV Technologies Stock Is Soaring Today

The company can now move forward with a late-stage study of its lead pipeline candidate.

DBVT : 3.21 (+0.63%)
Pre-Market Brief: Stocks Mixed As Strong Economic Data Fuel Rate Hike Worries

March S&P 500 futures (ESH23) are trending up +0.17% this morning after three major U.S. benchmark indices closed sharply lower on Thursday, with the technology-heavy Nasdaq dropping the most after stronger-than-expected...

ESH23 : 3,957.05s (-0.09%)
XPON : 2.14 (-0.47%)
TSLA : 430.99 (+2.36%)
AMC : 4.09 (-2.15%)
BTBT : 3.21 (-4.18%)
DBVT : 3.21 (+0.63%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DBV Technologies S.A. - DBVT

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of DBV Technologies S.A. (""DBV" or the "Company") (NASDAQ: DBVT). Such investors...

DBVT : 3.21 (+0.63%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DBV Technologies S.A. - DBVT

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of DBV Technologies S.A. (""DBV" or the "Company") (NASDAQ: DBVT). Such investors...

DBVT : 3.21 (+0.63%)
DBV Technologies Reports Second Quarter 2022 Financial Results

Montrouge, France, August 1, 2022 DBV Technologies Reports Second Quarter 2022 Financial Results DBV closes Q2 with a cash balance of $248M following...

DBVT : 3.21 (+0.63%)
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

AMF REGULATED INFORMATIONMontrouge, France, July 27, 2022 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBV Technologies...

DBVT : 3.21 (+0.63%)
Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2022

Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2022  (Article 223-16 of the...

DBVT : 3.21 (+0.63%)
2 Biotechs That Recently Soared -- Are They Buys?

Let's consider the risk-reward profile of these companies before jumping on the bandwagon.

AXSM : 86.44 (-4.73%)
DBVT : 3.21 (+0.63%)
DBV Technologies to Participate in Upcoming EAACI 2022 Congress

Montrouge, France, June 28, 2022 DBV Technologies to Participate in Upcoming EAACI 2022 Congress DBV Technologies (Euronext: DBV – ISIN: FR0010417345 –...

DBVT : 3.21 (+0.63%)

Business Summary

DBV Technologies SA is a biopharmaceutical company. It develops products and immunotherapies for the diagnosis and treatment of various food allergies, including milk and peanut. The Company delivers biological immunoactive compounds, such as allergens, to the immune system by targeting the antigen-presenting...

See More

Key Turning Points

3rd Resistance Point 3.51
2nd Resistance Point 3.35
1st Resistance Point 3.27
Last Price 3.21
1st Support Level 3.03
2nd Support Level 2.87
3rd Support Level 2.79

See More

52-Week High 10.70
Fibonacci 61.8% 7.45
Fibonacci 50% 6.45
Fibonacci 38.2% 5.45
Last Price 3.21
52-Week Low 2.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar